InspireMD, Inc. (NSPR)

InspireMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	6.21	5.17	4.5	2.49	3.72
Revenue Growth (YoY)	20.00%	15.04%	80.89%	-33.22%	3.33%
Cost of Revenue	4.4	4.05	3.74	2.4	2.97
Gross Profit	1.81	1.12	0.75	0.08	0.76
Selling, General & Admin	14.97	12.02	10.31	8.23	7.62
Research & Development	7.98	7.81	5.16	2.23	2.95
Operating Expenses	22.95	19.83	15.47	10.46	10.57
Operating Income	-21.14	-18.71	-14.72	-10.38	-9.82
Interest Expense / Income	0	0	0.16	0.16	0.2
Other Expense / Income	-1.29	-0.25	-	-	-
Pretax Income	-19.85	-18.46	-14.87	-10.54	-10.02
Income Tax	0.07	0.03	0.05	0	0.02
Net Income	-19.92	-18.49	-14.92	-10.54	-10.04
Shares Outstanding (Basic)	24	8	7	2	0
Shares Outstanding (Diluted)	24	8	7	2	0
Shares Change	208.29%	7.16%	385.71%	985.50%	352.83%
EPS (Basic)	-0.82	-2.35	-2.03	-6.97	-72.00
EPS (Diluted)	-0.82	-2.35	-2.03	-6.97	-72.00
Free Cash Flow	-16.75	-16.02	-13.55	-9.15	-10.09
Free Cash Flow Per Share	-0.69	-2.03	-1.84	-6.05	-72.45
Gross Margin	29.12%	21.60%	16.77%	3.34%	20.32%
Operating Margin	-340.74%	-361.88%	-327.39%	-417.71%	-263.80%
Profit Margin	-320.97%	-357.59%	-331.88%	-424.31%	-269.82%
Free Cash Flow Margin	-269.86%	-309.71%	-301.54%	-368.09%	-271.27%
EBITDA	-19.62	-18.28	-14.56	-10.23	-9.66
EBITDA Margin	-316.18%	-353.41%	-323.80%	-411.63%	-259.55%
Depreciation & Amortization	0.23	0.19	0.16	0.15	0.16
EBIT	-19.85	-18.46	-14.72	-10.38	-9.82
EBIT Margin	-319.92%	-357.05%	-327.39%	-417.71%	-263.80%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).